These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9192956)

  • 1. Potential clinical impact of normal-tissue intrinsic radiosensitivity testing.
    Bentzen SM
    Radiother Oncol; 1997 May; 43(2):121-31. PubMed ID: 9192956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
    Mackay RI; Hendry JH
    Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules.
    Burnet NG; Nyman J; Turesson I; Wurm R; Yarnold JR; Peacock JH
    Radiother Oncol; 1994 Dec; 33(3):228-38. PubMed ID: 7716263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed.
    Dikomey E; Borgmann K; Peacock J; Jung H
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1194-200. PubMed ID: 12829159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualization of dose prescription based on normal-tissue dose-volume and radiosensitivity data.
    Sanchez-Nieto B; Nahum AE; Dearnaley DP
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):487-99. PubMed ID: 11173145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck.
    Stausbøl-Grøn B; Overgaard J
    Radiother Oncol; 1999 Jan; 50(1):47-55. PubMed ID: 10225557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of high dose rate, low dose rate, and high dose rate fractionated radiation for optimizing differences in radiosensitivities in vitro.
    Wilkins RC; Ng CE; Raaphorst GP
    Radiat Oncol Investig; 1998; 6(5):209-15. PubMed ID: 9822167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity.
    Bentzen SM; Overgaard M; Overgaard J
    Eur J Cancer; 1993; 29A(10):1373-6. PubMed ID: 8398261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosensitivity of dermal and tumor fibroblasts derived from the same patient.
    Honkanen J; Rantanen V; Kulmala J; Grénman R; Klemi P; Pekkola K
    J Cancer Res Clin Oncol; 1998; 124(8):415-20. PubMed ID: 9750017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer.
    Barber JB; Burrill W; Spreadborough AR; Levine E; Warren C; Kiltie AE; Roberts SA; Scott D
    Radiother Oncol; 2000 May; 55(2):179-86. PubMed ID: 10799730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer.
    Brock WA; Tucker SL; Geara FB; Turesson I; Wike J; Nyman J; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1371-9. PubMed ID: 7635777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does skin fibroblast radiosensitivity predict squamous cancer cell radiosensitivity of the same individual?
    Haikonen J; Rantanen V; Pekkola K; Kulmala J; Grénman R
    Int J Cancer; 2003 Mar; 103(6):784-8. PubMed ID: 12516099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study.
    Vandevoorde C; Depuydt J; Veldeman L; De Neve W; Sebastià N; Wieme G; Baert A; De Langhe S; Philippé J; Thierens H; Vral A
    Int J Radiat Biol; 2016 Dec; 92(12):823-836. PubMed ID: 27586010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Describing patients' normal tissue reactions: concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity. Steering Committee of the BioMed2 European Union Concerted Action Programme on the Development of Predictive Tests of Normal Tissue Response to Radiation Therapy.
    Burnet NG; Johansen J; Turesson I; Nyman J; Peacock JH
    Int J Cancer; 1998 Dec; 79(6):606-13. PubMed ID: 9842969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro radiosensitivity of skin fibroblasts can identify a group of patients with complications in various health tissues after radiotherapy].
    Alsbeih G; Malone S; Grimard L; Raaphorst GP
    Cancer Radiother; 1999; 3(4):318-24. PubMed ID: 10486543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitivity of human cell lines to small doses. Are there some clinical implications?
    Malaise EP; Lambin P; Joiner MC
    Radiat Res; 1994 Apr; 138(1 Suppl):S25-7. PubMed ID: 8146319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitivity, repair capacity, and stem cell fraction in human soft tissue tumors: an in vitro study using multicellular spheroids and the colony assay.
    Stuschke M; Budach V; Klaes W; Sack H
    Int J Radiat Oncol Biol Phys; 1992; 23(1):69-80. PubMed ID: 1572832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Individual response to ionising radiation: What predictive assay(s) to choose?].
    Granzotto A; Joubert A; Viau M; Devic C; Maalouf M; Thomas C; Vogin G; Malek K; Colin C; Balosso J; Foray N
    C R Biol; 2011 Feb; 334(2):140-57. PubMed ID: 21333944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity?
    Tucker SL; Geara FB; Peters LJ; Brock WA
    Radiother Oncol; 1996 Feb; 38(2):103-13. PubMed ID: 8966222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity.
    Barnett GC; Kerns SL; Noble DJ; Dunning AM; West CM; Burnet NG
    Clin Oncol (R Coll Radiol); 2015 Oct; 27(10):579-87. PubMed ID: 26166774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.